Navigation Links
Sinovac Completes Construction of H1N1 Virus Seed Bank

s pandemic influenza vaccine (H5N1), has already been approved for government stockpiling. Sinovac is developing vaccines for enterovirus 71, universal pandemic influenza, Japanese encephalitis vaccine, and human rabies vaccine. Its wholly owned subsidiary, Tangshan Yian, is conducting field trials for independently developed inactivated animal rabies vaccines.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the business outlook and quotations from management in this press release contain forward-looking statements. Statements that are not historical facts, including statements about Sinovac's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. Sinovac does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

    Helen G. Yang
    Sinovac Biotech Ltd.
    Tel:  +86-10-8289-0088 x9871
    Fax:  +86-10-6296-6910

    Amy Glynn/Sara Pellegrino
    The Ruth Group
    Tel:  +1-646-536-7023/7002

    Janine McCargo
    The Ruth Group
    Tel:  656-536-7033
    Email:  jmccargo@the

SOURCE Sinovac Biotech Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sinovac Begins the Production of Influenza A (H1N1) Vaccine
2. Chinas Vice Premier, Li Keqiang, Visits Sinovac to Inspect H1N1 Vaccine Production Preparation
3. Sinovac to Host Conference Call to Report First Quarter 2009 Financial Results
4. Sinovac Biotech Ltd. Files Annual Report on Form 20-F
5. Sinovac Initiates Preparatory Activities for Swine Flu Vaccine
6. Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables
7. Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results
8. Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2008 Financial Results
9. Sinovac Biotech Co. Ltd., Sinovacs Beijing Subsidiary, Obtains High-Tech Enterprise Status
10. Sinovac Receives GMP Certification for its New Filling and Packaging Production Facility
11. Sinovac Enters Veterinary Vaccine Market with Inactivated Rabies Vaccine
Post Your Comments:
(Date:10/8/2015)...  Sigma-Aldrich Corporation (NASDAQ: SIAL ) announced ... its Applied Diagnostics and Testing business segment has ... line with ten certified Snap-N-Spike ® solutions ... their stable-labeled internal standards. These new solution certified ... acid and native and deuterium-labeled analogs of cholic ...
(Date:10/8/2015)... CANADA (PRWEB) , ... October 08, 2015 , ... ... has entered into an exclusive license agreement to develop and commercialize intellectual property ... upon the original agreement from February 2009, and affords exclusive worldwide rights to ...
(Date:10/7/2015)... 8, 2015 ... accounts for largest bioinformatics market share due ... discovery and development process says this research ... . --> ... of applications, the bioinformatics market is segmented ...
(Date:10/7/2015)... (PRWEB) , ... October 07, 2015 , ... Neil Riordan, ... Beach Anti-Aging Summit Tomorrow, October 8th, at Mar-a-Lago from 3:50 pm to 4:30 pm. ... adult stem cell therapy. , He is the Co-Founder and Chief Science ...
Breaking Biology Technology:
... DNDN ) today announced that Mitchell H. Gold, ... a company update at the,UBS Global Life Sciences Conference ... 1:30 p.m. ET., A live audio webcast of ... of the Dendreon website, . If you are ...
... /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex:,SVA), a vaccine-focused ... Yin, Chairman, president & CEO, will present at ... Beijing Hotel in New York City.,The Presentation is ... PM., About Sinovac, Sinovac Biotech Ltd. ...
... SAN DIEGO, Sept. 17 Ardea Biosciences, Inc.,(Nasdaq: RDEA ) ... Biosciences, will present at two upcoming investor,conferences., UBS Global ... Time: 1:00 p.m. Eastern Time ... , Third Annual JMP Securities Healthcare Focus Conference, ...
Cached Biology Technology:
(Date:9/28/2015)... 2015 According to a new ... Product (Scanner & Others), Application (Access Control & Others), ... & Geography Global - Forecast to 2020", published by MarketsandMarkets, ... 3627.90 Million by 2020, at a CAGR of 23.40% ... market data T ables and 66 ...
(Date:9/10/2015)... LONDON , Sept. 10, 2015 This ... dominate wearable technology products today, and emerging sensor types ... have risen through the peak of the wearable technology ... the slide to disillusionment. The common feature with all ... the key enabler for their most useful functions. Sensors ...
(Date:9/9/2015)... 9, 2015  NuData Security announced today that ... furthering the company,s commitment to protecting organizations and ... NuData Security,s online fraud detection solution, NuDetect, ... cycle. The product combines continual analysis and behavioral ... behavior from fraudulent behavior, allowing the company to ...
Breaking Biology News(10 mins):
... large population of loggerhead sea turtles that nest on ... have found an unexpected dichotomy in turtle behavior: While ... bottom-dwelling sea life in shallow coastal waters, others leave ... along the African coast and exhibit a distinct feeding ...
... researchers believed that stem cells in the bone marrow ... unaware of -- and unaffected by -- the daily ... so. , Scientists at the Oklahoma Medical Research Foundation ... that eventually give rise to the blood cells that ...
... has found all forms of tobacco exposure, whether that be ... of heart attack. , The study by professors Salim Yusuf ... Medicine at McMaster University and Hamilton Health Sciences in Hamilton, ... In collaboration with colleagues from 52 countries, they calculated the ...
Cached Biology News:
Mouse monoclonal [YPF19] to Yersinia pestis ( Abpromise for all tested applications)....
Rabbit polyclonal to 13,14 dihydro 15 keto Prostaglandin E2 ( Abpromise for all tested applications)....
DDO Immunogen: DDO (NP_003640, 270 a.a. ~ 370 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Arginine vasopressin receptor (AVP-V2), rat. The peptide used for immunization has no significant similarity with AVP V1a or V1b receptors....
Biology Products: